Table 4 SHR erythrocyte polyunsaturated fatty acid composition (%total fatty acids) following the consumption of diets with a 25:1 ω-6/ω-3 FAR for 6 weeks^§

Linoelaidic

C18:2n6t

nd

nd

nd

nd

nd

Linoleic

C18:2n6c

3.68 ± 0.31^a

9.26 ± 0.25^b

8.69 ± 0.12^b

9.15 ± 0.19^b

10.31 ± 0.37^c

γ-Linolenic

C18:3n6

0.23 ± 0.02^a

0.63 ± 0.31^a

8.48 ± 1.29^b

6.43 ± 2.09^b

5.07 ± 1.55^b

α-Linolenic

C18:3n3

0.10 ± 0.04^a

0.09 ± 0.02^a

0.24 ± 0.07^a

0.48 ± 0.22^a

0.31 ± 0.02^a

Eicosadienoic

C20:2n6

0.20 ± 0.03^a

nd

0.51 ± 0.02^bc

0.56 ± 0.03^c

0.44 ± 0.03^b

Eicosatrienoic

C20:3n6

0.19 ± 0.05^a

0.43 ± 0.01^b

0.40 ± 0.03^b

0.40 ± 0.02^b

0.57 ± 0.03^c

Arachidonic

C20:4n6

12.25 ± 2.11^a

22.65 ± 2.37^b

22.41 ± 1.69^b

22.09 ± 1.76^b

21.67 ± 0.87^b

Eicosatrienoic

C20:3n3

nd

0.16 ± 0.03^a

0.17 ± 0.01^a

nd

nd

Eicosapentaenoic

C20:5n3

nd

0.29 ± 0.07^a

nd

nd

1.41 ± 0.23^b

Docosadienoic

C22:2n6

nd

nd

nd

nd

nd

Docosatetraenoic

C22:4n6

1.30 ± 0.24^a

2.26 ± 0.60^b

2.02 ± 0.17 ^ab

2.79 ± 0.34^b

1.67 ± 0.33^ab

Docosatrienoic

C22:3n3

0.78 ± 0.23^a

1.12 ± 0.12^a

0.84 ± 0.08^a

1.07 ± 0.18^a

0.71 ± 0.12^a

Docosapentaenoic

C22:5n3

nd

nd

nd

nd

nd

Docosahexaenoic

C22:6n3

0.68 ± 0.08^a

3.19 ± 0.52^bc

1.78 ± 0.15^ab

3.86 ± 1.61^c

4.48 ± 0.67^c

Total PUFAs

19.32 ± 2.81 ^a

40.30 ± 2.91 ^b

45.50 ± 2.95 ^b

46.70 ± 1.49 ^b

46.51 ± 1.04 ^b